Novartis says operating profit to grow again ahead of Sandoz spin off
The Swiss drugmaker reported full-year core operating income was broadly flat at $16.7 billion. Source link
Read moreThe Swiss drugmaker reported full-year core operating income was broadly flat at $16.7 billion. Source link
Read moreInvestors are looking for a fresh start for the markets after 2022 hit several sectors hard. Since September, "Fast Money"
Read moreHere are the biggest calls on Wall Street on Source link
Read moreHere are the biggest calls on Wall Street on Source link
Read moreHere are the biggest calls on Wall Street on Source link
Read moreInvestors seeking returns in a beaten-down market could turn to companies buying back their shares. Goldman names the stocks it
Read moreBernstein has named a raft of global stocks that it says could benefit from the rising strength of the U.S.
Read moreNames on the move ahead of the open. Source link
Read moreTurkey and West climb down from brink of biggest diplomatic crisis CNBC Source link
Read more